Perry H. Moore

2.0k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Perry H. Moore is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Perry H. Moore has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Perry H. Moore's work include Estrogen and related hormone effects (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Hormonal and reproductive studies (5 papers). Perry H. Moore is often cited by papers focused on Estrogen and related hormone effects (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Hormonal and reproductive studies (5 papers). Perry H. Moore collaborates with scholars based in United States, Canada and Czechia. Perry H. Moore's co-authors include Steven M. Paul, R. H. Purdy, A. Leslie Morrow, P. Narasimha Rao, David R. Rubinow, Peter J. Schmidt, P. Narasimha Rao, Robert H. Purdy, David L. Rainwater and Wendy Shelledy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and FEBS Letters.

In The Last Decade

Perry H. Moore

27 papers receiving 1.7k citations

Hit Papers

Stress-induced elevations of gamma-aminobutyric acid type... 1991 2026 2002 2014 1991 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perry H. Moore United States 15 664 562 500 439 368 27 1.8k
Hemmie H.G. Berendsen Netherlands 23 179 0.3× 732 1.3× 308 0.6× 503 1.1× 379 1.0× 36 1.8k
S. K. Quadri United States 24 454 0.7× 180 0.3× 271 0.5× 382 0.9× 159 0.4× 56 1.5k
Helen M. Chao United States 26 676 1.0× 401 0.7× 294 0.6× 321 0.7× 525 1.4× 41 1.7k
William J. Millard United States 31 345 0.5× 627 1.1× 165 0.3× 913 2.1× 680 1.8× 87 2.9k
Margarethe Holzbauer Slovakia 21 247 0.4× 396 0.7× 208 0.4× 314 0.7× 292 0.8× 49 1.4k
Fong‐Sen Wu United States 13 385 0.6× 902 1.6× 268 0.5× 157 0.4× 616 1.7× 17 1.5k
J.F. Bruni United States 17 364 0.5× 1.0k 1.8× 269 0.5× 616 1.4× 571 1.6× 19 1.9k
R.R. Sakai United States 17 519 0.8× 214 0.4× 376 0.8× 336 0.8× 220 0.6× 26 1.3k
Augusto V. Juorio Canada 23 183 0.3× 701 1.2× 138 0.3× 244 0.6× 465 1.3× 50 1.6k
John M. Streicher United States 25 262 0.4× 845 1.5× 196 0.4× 179 0.4× 1.1k 2.9× 83 2.3k

Countries citing papers authored by Perry H. Moore

Since Specialization
Citations

This map shows the geographic impact of Perry H. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry H. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry H. Moore more than expected).

Fields of papers citing papers by Perry H. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry H. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry H. Moore. The network helps show where Perry H. Moore may publish in the future.

Co-authorship network of co-authors of Perry H. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Perry H. Moore. A scholar is included among the top collaborators of Perry H. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry H. Moore. Perry H. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rainwater, David L., et al.. (2004). Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins. Journal of Lipid Research. 45(4). 773–775. 23 indexed citations
2.
Rainwater, David L., Candace M. Kammerer, K. Dee Carey, et al.. (2002). Genetic determination of HDL variation and response to diet in baboons. Atherosclerosis. 161(2). 335–343. 16 indexed citations
3.
Wang, Zhiqiang, et al.. (1998). Synthesis of New Immunogens for Estrone and Estradiol-17β and Antisera Evaluation. Steroids. 63(3). 141–145. 4 indexed citations
4.
Rainwater, David L., et al.. (1997). Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. Journal of Lipid Research. 38(6). 1261–1266. 67 indexed citations
5.
Rainwater, David L., John Blangero, Perry H. Moore, Wendy Shelledy, & Thomas D. Dyer. (1995). Genetic control of apolipoprotein A-I distribution among HDL subclasses. Atherosclerosis. 118(2). 307–317. 14 indexed citations
6.
Singh, Amareshwar T.K., David L. Rainwater, Steven M. Haffner, et al.. (1995). Effect of Diabetes on Lipoprotein Size. Arteriosclerosis Thrombosis and Vascular Biology. 15(11). 1805–1811. 68 indexed citations
7.
Lai, Chii‐Ming, Perry H. Moore, & Check Y. Quon. (1995). Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.. PubMed. 88(1). 51–62. 21 indexed citations
8.
Schmidt, Peter J., R. H. Purdy, Perry H. Moore, Steven M. Paul, & David R. Rubinow. (1994). Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.. The Journal of Clinical Endocrinology & Metabolism. 79(5). 1256–1260. 160 indexed citations
9.
Rodriguez, Angela M., et al.. (1992). A direct radioimmunoassay for 5α-androstane-3α,17β-diol 17-glucuronide. Steroids. 57(5). 216–221. 7 indexed citations
10.
Purdy, Robert H., Perry H. Moore, P. Narasimha Rao, et al.. (1990). Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids. 55(7). 290–296. 191 indexed citations
12.
Moore, Perry H., et al.. (1987). Isolation and identification of androstanediol glucuronide from human plasma. Journal of Steroid Biochemistry. 28(5). 565–569. 14 indexed citations
13.
Newburger, Jerold, V. Daniel Castracane, Perry H. Moore, Mary C. Williams, & Joseph W. Goldzieher. (1983). The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon. American Journal of Obstetrics and Gynecology. 146(1). 80–87. 10 indexed citations
14.
Rao, P. Narasimha, Robert H. Purdy, Perry H. Moore, & Joseph W. Goldzieher. (1980). Synthesis of new steroid haptens for radioimmunoassay—VI. 3-O-carboxymethyl ether derivatives of equine estrogens. Highly specific antisera for measurement of equilin and 17α-dihydroequilin in plasma. Journal of Steroid Biochemistry. 13(11). 1291–1298. 4 indexed citations
15.
Rao, P. Narasimha, Robert H. Purdy, Mary C. Williams, et al.. (1979). Metabolites of estradiol-17β in bovine liver: Identification of the 17-β-d-glucopyranoside of estradiol-17α. Journal of Steroid Biochemistry. 10(2). 179–185. 9 indexed citations
19.
Rao, P. Narasimha, Perry H. Moore, & Joseph W. Goldzieher. (1974). Specific antisera suitable for solid-phase radioimmunoassay of 11β-hydroxyandrost-4-ene-3,17-dione. Steroids. 24(6). 793–801. 11 indexed citations
20.
Moore, Perry H. & Leonard R. Axelrod. (1972). A solid-phase radioimmunoassay for estrogen by estradiol-17β antibody covalently bound to a water insoluble synthetic polymer (enzacryl AA). Steroids. 20(2). 199–212. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026